Company / Inventory
AbbVie Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$5.0B
FY2025
5-year range
$3.1B / $5.0B
FY2021-FY2025
Trend
+18.4%
vs FY2024
Sector context
#6 of 108
Health Care
What the data says
Among 108 Health Care companies, AbbVie is in the top 6% for inventory. Inventory has increased for 4 consecutive years, from $3.1B in FY2021 to $5.0B in FY2025.
Based on SEC 10-K filings.
$5.0B in FY2025 with a 5-year CAGR of +8.4%. Top quartile in the Health Care sector.
Improved from $4.1B to $5.0B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 108This company $5.0B Sector average $862.4M
▼
+474.1% above sector average
Key checks
Key Insights
- AbbVie's inventory has grown for 4 consecutive years.
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, inventory increased 18.4% year-over-year.
- Ranks #6 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0B | +18.4% |
| FY2024 | $4.2B | +2.0% |
| FY2023 | $4.1B | +14.5% |
| FY2022 | $3.6B | +14.4% |
| FY2021 | $3.1B | -5.5% |
| FY2020 | $3.3B | +82.6% |
| FY2019 | $1.8B | +13.0% |
| FY2018 | $1.6B | +0.0% |
| FY2017 | $1.6B | +11.1% |
| FY2016 | $1.4B | -16.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026